Current Value of Holding

$16.4 Million

Shares

65.4 Thousand

% of Portfolio

0.02%

Average Buy Price

$170

Avg closing price
Price range

44 Ken Griffin Alnylam Pharmaceuticals Trades

Ken Griffin's position in Alnylam Pharmaceuticals is currently worth $25.9 Million. That's 0.03% of their equity portfolio (730th largest holding). The first Alnylam Pharmaceuticals trade was made in Q2 2013. Since then Ken Griffin bought shares 52 more times and sold shares on 57 occasions. The stake costed the investor $12.8 Million, netting the investor a gain of 103% so far.

Avg closing price
Price range
Increased shares by 173.2% (+41.5 Thousand shares) Q4 2024
Avg closing price $262.40
Price range $232.27 - $300.55
Sold 93.5% shares (-343 Thousand shares) Q3 2024
Avg closing price $260.22
Price range $233.81 - $287.01
Increased shares by 818.6% (+327 Thousand shares) Q2 2024
Avg closing price $157.87
Price range $143.31 - $247.00
Sold 40.0% shares (-26.7 Thousand shares) Q1 2024
Avg closing price $166.82
Price range $146.51 - $198.20
New holding (+66.6 Thousand shares) Q4 2023
Avg closing price $170.34
Price range $151.41 - $196.57
Sold -29.6 Thousand shares Q3 2023
Avg closing price $190.79
Price range $170.77 - $211.65
Sold 71.7% shares (-74.8 Thousand shares) Q2 2023
Avg closing price $198.26
Price range $185.01 - $212.05
Increased shares by 7145.6% (+103 Thousand shares) Q1 2023
Avg closing price $210.20
Price range $182.66 - $235.53
Sold 98.3% shares (-81.1 Thousand shares) Q4 2022
Avg closing price $213.29
Price range $185.11 - $241.31
Increased shares by 973.2% (+74.9 Thousand shares) Q3 2022
Avg closing price $190.40
Price range $138.54 - $233.85
Increased shares by 265.0% (+5.59 Thousand shares) Q2 2022
Avg closing price $141.87
Price range $120.42 - $169.29
Sold 97.0% shares (-68.7 Thousand shares) Q1 2022
Avg closing price $152.35
Price range $127.18 - $173.91
Increased shares by 238.9% (+49.9 Thousand shares) Q4 2021
Avg closing price $185.86
Price range $159.56 - $209.29
Sold 46.4% shares (-18.1 Thousand shares) Q3 2021
Avg closing price $187.58
Price range $169.75 - $207.73
Sold 68.4% shares (-84.3 Thousand shares) Q2 2021
Avg closing price $146.46
Price range $128.63 - $176.89
Increased shares by 364.4% (+96.7 Thousand shares) Q1 2021
Avg closing price $150.49
Price range $126.83 - $175.69
Sold 64.0% shares (-47.2 Thousand shares) Q3 2020
Avg closing price $142.11
Price range $121.19 - $165.49
Sold 33.2% shares (-36.7 Thousand shares) Q2 2020
Avg closing price $134.81
Price range $104.21 - $156.44
Increased shares by 36.6% (+29.6 Thousand shares) Q1 2020
Avg closing price $115.43
Price range $93.12 - $133.99
Increased shares by 0.5% (+367 shares) Q4 2019
Avg closing price $99.70
Price range $74.51 - $124.23

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!